Respiratory Devices Market Growth Opportunities: 2024 to 2034

Q: What was the overall Value of the Respiratory Device Market in 2023?

The market valuation in 2023 was US$ 24,623 million. Read Report

Respiratory Device Market Outlook from 2024 to 2034

Respiratory devices, in the light of combination therapies for the treatment of COPD and asthma, have made significant strides toward market growth. The recent COVID pandemic has also brought in front of healthcare professionals, the significance of respiratory devices as major tools for mitigating the spread and severity of respiratory illnesses. This is set to take the market valuation to an astounding US$ 26873.7 million in 2024.

Medicare advancements, thanks to the hefty investments by private as well as public healthcare companies have also amplified the acceptance and adoption of these devices in the developed and developing parts of the world. As the industry analysis exhibits an outstanding growth of 9.90% CAGR through 2034, the future prospects of the respiratory device market seem very lucrative.

Manufacturers involved in the production and distribution of these devices are also curating equipment that is not only effective but also affordable to the general populace. Despite the advent of alternative methodologies and treatments, the market valuation is very likely to surpass US$ 69,072.5 million by the end of 2034. Medical inclusion policies and initiatives by governments in underdeveloped and developing countries are also bringing an enormous number of people under the purview of the respiratory device market.

Attributes	Details
Market Value for 2024	US$ 26,873.7 million
Projected Market Value for 2034	US$ 69,072.5 million
Value-based CAGR of the Market for 2024 to 2034	9.90%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Category-wise Insights

Positive Airway Pressure Devices Retain their Dominance in the Healthcare Sector

Various types of respiratory devices have flooded the market, thanks to the advent of numerous companies in the market. Home oxygen concentrators, portable oxygen devices, positive airway pressure devices, etc., are some of the prominent ones. Among these, positive airway pressure devices are estimated to hold a market share of 31.30% in 2024.

Attributes	Details
Product	Positive Airway Pressure Devices
Market Share (2024)	31.30%

The demand for positive airway pressure devices in the healthcare sector is touching the skies as they offer effective treatment for sleep apnea and other respiratory disorders. These devices are also inexpensive ways to improve quality of life and reduce the risk of complications associated with respiratory diseases.
Positive airway pressure devices also offer significant benefits in reducing daytime fatigue. This feature of it has increased its popularity among the daily office-goers and frequent travelers who struggle with sleep disturbances.

Hospitals Consume Almost Half Respiratory Devices

Respiratory devices find their applications in a wide spectrum of healthcare facilities such as hospitals, ambulatory surgical centers, clinics, long-term care centers, etc. Hospitals to take the largest share of 40.70% of the overall market in 2024.

Attributes	Details
End User	Hospitals
Market Share (2024)	40.70%

The clamor for respiratory equipment in the hospitals is touching the skies, especially post-pandemic, as they are vital for treating patients with severe respiratory complications such as pneumonia, acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary disease (COPD).
Hospitals are also generating substantial demand for respiratory equipment as they offer proper airway management and ventilation during surgical procedures.

Country-wise Insights

Countries	CAGR (2024 to 2034)
Germany	12.10%
France	11.90%
India	11.40%
Canada	10.30%
Mexico	10.10%

Mergers and Acquisitions to Shape the Future of Germany’s Respiratory Device Market

The market in Germany is a promising one. It is slated to surge at a CAGR of 12.10% through 2034.

Responding to the growing demand for sophisticated, modern, and AI-driven connected respiratory devices, companies involved in the manufacturing of respiratory aids are partnering up with software companies.
Partnerships and acquisitions are common in the country as they give both companies opportunities to take advantage of each other’s expertise. For instance, in June 2022, ResMed finalized the acquisition of Medifox Dan, a German out-of-hospital software firm. The deal, focused on respiratory devices, bolstered ResMed's capabilities in providing tools for staffing plans and care documentation to healthcare providers.

Sophisticated Medical Infrastructure Supports the Adoption of Respiratory Aids in France

France is also one of the most lucrative countries in this market. It is very likely to rise at a CAGR of 11.90%.

When it comes to a well-established healthcare sector, France is considered one of the most advanced countries, not just in Europe but all over the world. Each year, millions of patients flock to the nation to take advantage of its advanced medical facilities.
This creates a conducive environment for healthcare facilities such as hospitals, ambulatory surgical centers, clinics, etc., to accept and adopt these respiratory equipment for the treatment process of various diseases associated with lung functions.

Government Initiatives to Benefit India’s Respiratory Device Market

The future of the market in India also looks very bright. The market is slated to progress at a CAGR of 11.40% through 2034.

The Indian government in the last few years has announced a multitude of schemes and policies to medically include a substantial portion of its population in the country’s healthcare sector. This has increased the need for respiratory devices in the country as hospitals are increasingly adopting these devices.
The country’s overall improvement in the healthcare infrastructure, especially after the pandemic, has also made it easier for healthcare facilities to acquire and install respiratory devices, thus amplifying the market prospects in the country.

Made-in-Canada Devices to Help Elderly Patients Breathe

Canada’s respiratory device market is slated to inflate at a CAGR of 10.30% from 2024 to 2034.

Canada has always been a frontrunner in medical advancements, thanks to the industry-academia collaboration in the country. The presence of world-class medical institutes in the country has led to the development of suave respiratory aids in Canada.
In March 2021, St. Clair College collaborated with Windsor-based researchers to develop the Canada Hood, a ventilation device aiding critically ill patients. Built by Crest Mold Technology Inc., it aimed to address respiratory challenges during the COVID-19 pandemic.

Mexico’s Respiratory Device Market to Profit amidst Rising Smog

The respiratory aid market in Mexico is also very likely to flourish in the coming years. It is slated to inflate at a CAGR of 10.10% through 2034.

Mexico is known for its agricultural activities. However, people’s tendency to burn waste after the harvest generates a substantial amount of smog in the environment. This has amplified the adoption of respiratory devices in the country.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Competitive Landscape

The market, globally, is a well-established one with a multitude of companies vying for international dominance. Hospitals, ambulatory surgical centers, clinics, etc., heavily rely on these companies for their respiratory requirements. These companies are also pouring billions of dollars into the development of product offerings that are not only effective but also affordable for the general populace.

Recent Developments

In February 2024, ResMed launched its AirCurve 11 series, featuring bilevel-positive airway pressure devices in the USA The devices utilized inspiratory and expiratory positive airway pressure, aiding sleep apnea treatment with improved comfort and compliance.
In August 2023, researchers from the University of Canterbury developed BOB, a tool unlocking respiratory data from devices. It facilitated data-driven respiratory care, reducing costs and wait times for patients. The software, developed by UC Engineering PhD students, provided real-time data interpretation and report generation for GPs.
In February 2024, Dräger was honored with Frost & Sullivan's Company of the Year Award in global respiratory care, recognizing its innovative solutions and customer impact. The award highlighted Dräger's commitment to excellence in medical technologies and services.
In February 2024, University Medical Devices secured US$ 1.6 million in seed funding to launch MicroWash, a groundbreaking nasal specimen collection device. The investment aimed to advance infrastructure and bring the device to market, addressing respiratory infections with a more comfortable alternative to nasal swabs.
In April 2024, Clario announced its acquisition of AI-powered software company ArtiQ, bolstering its Respiratory Solutions portfolio. The integration of ArtiQ's technology with Clario's devices enhanced data quality and patient experience in respiratory clinical trials.
In June 2023, SunMed acquired Avanos Medical's respiratory health business for US$ 110 million. The deal included inventory, assets, and leases for manufacturing facilities in Mexico. This expanded SunMed's portfolio after purchasing Vyaire Medical's hardware earlier that year.
In July 2023, ResMed acquired Somnoware, a software maker specializing in sleep and respiratory diagnostics. This strategic move bolstered ResMed's position in the market, particularly amidst competitor challenges.
In October 2022, Australia-based firm AirPhysio launched respiratory devices in Chennai, India. Brett Lee, former Australian cricketer, unveiled the AirPhysio and Better Breathing product range alongside Apollo Hospital’s managing director Suneeta Reddy. The company partnered with Medsmart and Apollo Group for the rollout.

Key Companies

Massimo Corporation
Teleflex Incorporated
Fisher & Paykel Healthcare Limited
ResMed Inc.
Hamilton Medical AG
Medtronic plc.
Koninklijke Philips N.V.
Smith’s Medical
General Electric Healthcare Limited
Drägerwerk AG & Co. KGaA
Inogen Inc.

Key Coverage in the Respiratory Device Market

Demand Analysis of Respiratory Devices For COPD
Overview of Airway Devices in Anesthesia
Market Insights on Breathing Aids
Industrial Analysis of Breathing Aids for Sleep Apnea
Emerging Trends in the Respiratory Device Market

Key Segments of the Respiratory Device Industry

Product Categories:

Respiratory Consumables
- Respiratory Masks
- Nasal Cannulas
- Oxygen Tubing Sets
- Breathing Filters
Nebulizers
- Compressed Jet Nebulizers
- Ultrasonic Nebulizers
Oxygen Concentrators
- Home Oxygen Concentrators
- Portable Oxygen Concentrators
- Positive Airway Pressure (PAP) Devices
- Polysomnography Devices
- Ambulatory PSG Devices
- Clinical PSG Devices
- Pulse Oximeters
- Mechanical Ventilators
- Spirometers

End Users:

Hospitals
Ambulatory Surgical Centers
Clinics
Long Term Care Centers
Others

Regions:

North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa (MEA)

Frequently Asked Questions

How much is the Respiratory Device Market Currently Worth?

The market is expected to be worth US$ 26,873.7 million in 2024.

What is the Sales Forecast for Respiratory Devices through 2034?

The respiratory device market is expected to reach US$ 69,072.5 million by 2034.

At What Rate is the Respiratory Device Market growing?

The market is set to develop at a CAGR of 9.90% from 2024 to 2034.

Which are the key Companies in the Market?

Massimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, ResMed Inc., Hamilton Medical AG, Medtronic plc, and Koninklijke Philips N.V., are some of the major players in the market.

What was the overall Value of the Respiratory Device Market in 2023?

The market valuation in 2023 was US$ 24,623 million.

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Manufacturer
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034
5.3.1. Respiratory Consumables
5.3.1.1. Respiratory Mask
5.3.1.2. Nasal Cannulas
5.3.1.3. Oxygen Tubing Sets
5.3.1.4. Breathing Filters
5.3.2. Oxygen Concentrators
5.3.2.1. Home Oxygen Concentrators
5.3.2.2. Portable Oxygen
5.3.2.3. Concentrators`
5.3.2.4. Positive Airway Pressure (PAP) Devices
5.3.2.5. Polysomnography Devices
5.3.2.6. Ambulatory PSG Devices
5.3.2.7. Clinical PSG Devices
5.3.2.8. Pulse Oximeters
5.3.2.9. Mechanical Ventilators
5.3.2.10. Spirometers
5.3.3. Nebulizers
5.3.3.1. Compressed Jet Nebulizers
5.3.3.2. Ultrasonic Nebulizers
5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Users
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Users, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Users, 2024 to 2034
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Clinics
6.3.4. Long Term Care Centers
6.3.5. Others
6.4. Y-o-Y Growth Trend Analysis By End Users, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By End Users, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By End Users
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By End Users
8.4. Key Takeaways
9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By End Users
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By End Users
9.4. Key Takeaways
10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Product
10.2.3. By End Users
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By End Users
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Product
11.2.3. By End Users
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By End Users
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Product
12.2.3. By End Users
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By End Users
12.4. Key Takeaways
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By End Users
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By End Users
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By End Users
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By End Users
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2023
15.1.2.1. By Product
15.1.2.2. By End Users
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2023
15.2.2.1. By Product
15.2.2.2. By End Users
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2023
15.3.2.1. By Product
15.3.2.2. By End Users
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2023
15.4.2.1. By Product
15.4.2.2. By End Users
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2023
15.5.2.1. By Product
15.5.2.2. By End Users
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2023
15.6.2.1. By Product
15.6.2.2. By End Users
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2023
15.7.2.1. By Product
15.7.2.2. By End Users
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2023
15.8.2.1. By Product
15.8.2.2. By End Users
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2023
15.9.2.1. By Product
15.9.2.2. By End Users
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2023
15.10.2.1. By Product
15.10.2.2. By End Users
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2023
15.11.2.1. By Product
15.11.2.2. By End Users
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2023
15.12.2.1. By Product
15.12.2.2. By End Users
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2023
15.13.2.1. By Product
15.13.2.2. By End Users
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2023
15.14.2.1. By Product
15.14.2.2. By End Users
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2023
15.15.2.1. By Product
15.15.2.2. By End Users
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2023
15.16.2.1. By Product
15.16.2.2. By End Users
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2023
15.17.2.1. By Product
15.17.2.2. By End Users
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2023
15.18.2.1. By Product
15.18.2.2. By End Users
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2023
15.19.2.1. By Product
15.19.2.2. By End Users
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2023
15.20.2.1. By Product
15.20.2.2. By End Users
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2023
15.21.2.1. By Product
15.21.2.2. By End Users
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2023
15.22.2.1. By Product
15.22.2.2. By End Users
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2023
15.23.2.1. By Product
15.23.2.2. By End Users
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By End Users
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Massimo Corporation
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Teleflex Incorporated
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Fisher & Paykel Healthcare Limited
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. ResMed Inc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Hamilton Medical AG
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Medtronic plc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Koninklijke Philips N.V.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Smith’s Medical
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. General Electric Healthcare Limited
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Drägerwerk AG & Co. KGaA
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Inogen Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Respiratory Device Market

Respiratory Device Market Forecast by Nebulizers and Oxygen Concentrators for 2024 to 2034